Usually this time of year, the who’s who of the Life Sciences’ world have their eyes firmly on the US with the annual meeting of the American Society of Clinical Oncology (ASCO). Chicago becomes a battleground for over 30,000 doctors and scientists jostling with companies vying and hoping to get their clinical data in front of the right people.
08 Jun 2015
Life Sciences Review - London calling to the faraway biotech: Now a bubble is declared and IPOs hail down
Deltex Medical Group plc (DEMG:LON), 0.1 | Abaco Capital (ABA:LON), 0 | Agronomics Limited (ANIC:LON), 8.0 | Plethora Solutions (PLE:LON), 0 | Benchmark Holdings Plc (BMK:LON), 43.2 | Taihua (TAIH:LON), 0 | Electrical Geodesics (EGIC:LON), 0 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Verona Pharma plc Sponsored ADR (VRNA:NAS), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Life Sciences Review - London calling to the faraway biotech: Now a bubble is declared and IPOs hail down
Deltex Medical Group plc (DEMG:LON), 0.1 | Abaco Capital (ABA:LON), 0 | Agronomics Limited (ANIC:LON), 8.0 | Plethora Solutions (PLE:LON), 0 | Benchmark Holdings Plc (BMK:LON), 43.2 | Taihua (TAIH:LON), 0 | Electrical Geodesics (EGIC:LON), 0 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Verona Pharma plc Sponsored ADR (VRNA:NAS), 0
- Published:
08 Jun 2015 -
Author:
Derren Nathan -
Pages:
12
Usually this time of year, the who’s who of the Life Sciences’ world have their eyes firmly on the US with the annual meeting of the American Society of Clinical Oncology (ASCO). Chicago becomes a battleground for over 30,000 doctors and scientists jostling with companies vying and hoping to get their clinical data in front of the right people.